Creation date : 2024-07-03 Ι Author : Manager Ι View count : 824
CEO of our company, contributed a special project (Topic: CAR-T treatment) consisting of three part to commemorate the 1st anniversary of the founding of the pharmaceutical bio-specialized media "THE BIO."
For more details, please refer to the link below.
![]() |
[THE BIO] Kang Taejin, Renhaim’s CEO "We will compete with the Idiotype cancer vaccine and BAFFR CAR-T" | 2024-04-16 |
![]() |
[The Bio] Special Contribution (Topic: CAR-T Treatment) ② | 2024-07-04 |